Table 4.
Incidence of bacterial UTI after transrectal fiducials.
|
Author |
Institution |
No. of patients (dates) |
Antibiotic prophylaxis |
UTIs |
| Berglund et al [6] | Cleveland Clinic | 50 (2008-2010) | Cipro | 10% |
| Langenhuijsen et al [7] | University of Nijmegen | 209 (2001-2005) | Cipro | 1.9% |
| Igdem et al [8] | Istanbul Bilim University | 135 (2005-2008) | Cipro | 2.2% |
| Linden et al [9] | Jefferson University | 98 (2003-2006) | Quinolones | 0% |
| Brown et al [10] | Princess Alexandra Hospital | 20 (2007) | Trimethoprim | 5% |
| Thompson et al [11] | Peter McCallum Cancer Center | 28 (2007) | Cipro | 0% |
| Kably et al [12] | University of Miami | 75 (2010-2013) | Cipro | 2.7% |
| Loh et al [13] | Calvary Mater Newcastle Hospital | 285 (2012-2013) | Quinolones | 2.8%* |
Abbreviation: UTI, urinary tract infection.
*
Required hospitalization.
Borrowed with permission from Mendenhall WM, Costa JA, Williams CR, Harris SE, Mandia SE, Hoppe BS, Henderson RH, Bryant CM, Nichols RC, Mendenhall NP. Bacterial Urinary Tract Infection after Fiducial Marker Placement or Prostate Biopsy. Int J Particle Ther. 2014;1(3):745–758.